<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(24)</volume><submitter>Xin JF</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>This study investigated the correlation between cardiac function parameters by cardiac computed tomography (CT) and the clinical outcomes of heart failure patients with preserved ejection fraction (HFpEF) to provide experimental data for the diagnosis of HFpEF.&lt;h4>Methods&lt;/h4>A total of 157 HFpEF patients admitted to our hospital from January 2017 to January 2019 were retrospectively analyzed. The patients were divided into event and non-event groups according to the occurrence or absence of adverse events. Cardiac function parameters, such as the left ventricular (LV) end-diastolic volume (LVEDV) and LV end-diastolic volume index (LVEDVI), were obtained via CT scan. Also, the N-terminal-pro hormone b-type natriuretic peptide (NT-proBNP) levels in patients' serum were me</pubmed_abstract><journal>Annals of translational medicine</journal><pagination>1319</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9843394</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A retrospective study on the clinical significance of cardiac computed tomography in heart failure patients with preserved ejection fraction.</pubmed_title><pmcid>PMC9843394</pmcid><pubmed_authors>Huang LL</pubmed_authors><pubmed_authors>Fang QJ</pubmed_authors><pubmed_authors>Zhang LY</pubmed_authors><pubmed_authors>Lin LJ</pubmed_authors><pubmed_authors>Xin JF</pubmed_authors><pubmed_authors>Liu XF</pubmed_authors></additional><is_claimable>false</is_claimable><name>A retrospective study on the clinical significance of cardiac computed tomography in heart failure patients with preserved ejection fraction.</name><description>&lt;h4>Background&lt;/h4>This study investigated the correlation between cardiac function parameters by cardiac computed tomography (CT) and the clinical outcomes of heart failure patients with preserved ejection fraction (HFpEF) to provide experimental data for the diagnosis of HFpEF.&lt;h4>Methods&lt;/h4>A total of 157 HFpEF patients admitted to our hospital from January 2017 to January 2019 were retrospectively analyzed. The patients were divided into event and non-event groups according to the occurrence or absence of adverse events. Cardiac function parameters, such as the left ventricular (LV) end-diastolic volume (LVEDV) and LV end-diastolic volume index (LVEDVI), were obtained via CT scan. Also, the N-terminal-pro hormone b-type natriuretic peptide (NT-proBNP) levels in patients' serum were me</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T08:29:26.116Z</modification><creation>2025-04-04T08:29:26.116Z</creation></dates><accession>S-EPMC9843394</accession><cross_references><pubmed>36660728</pubmed><doi>10.21037/atm-22-5549</doi></cross_references></HashMap>